A detailed history of Franklin Resources Inc transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 80,786 shares of NRIX stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,786
Previous 64,472 25.3%
Holding current value
$2.02 Million
Previous $947,000 78.04%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.02 - $21.3 $196,094 - $347,488
16,314 Added 25.3%
80,786 $1.69 Million
Q1 2024

May 13, 2024

BUY
$7.77 - $15.66 $325,182 - $655,386
41,851 Added 185.01%
64,472 $947,000
Q4 2023

Feb 09, 2024

SELL
$4.25 - $10.71 $46 - $117
-11 Reduced 0.05%
22,621 $233,000
Q3 2023

Nov 13, 2023

SELL
$7.86 - $10.08 $2,035 - $2,610
-259 Reduced 1.13%
22,632 $177,000
Q2 2023

Aug 11, 2023

BUY
$8.7 - $13.28 $199,151 - $303,992
22,891 New
22,891 $228,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.18B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.